Novo Nordisk’s blockbuster weight-loss drug Ozempic is now being tested in Alzheimer’s patients in global trials that may redefine how metabolism links to brain healthNovo Nordisk’s blockbuster weight-loss drug Ozempic is now being tested in Alzheimer’s patients in global trials that may redefine how metabolism links to brain health Latest News [ SOBAN NEWS: International and National ]